The NET Alliance is a long-term commitment by Novartis Oncology to engage both healthcare professionals and patients in a global effort to improve the knowledge and management of neuroendocrine tumors, known as NET.
The NET Alliance has offered information, support, and resources to the entire NET community of healthcare professionals, researchers, patients, and caregivers. The NET Alliance is committed to helping you understand neuroendocrine cancer and what you can do to live with your disease.
With support from Novartis Oncology and the NET community, The NET Alliance continues to
- Advance knowledge and understanding of neuroendocrine tumors
- Improve early diagnosis of neuroendocrine tumors
- Foster collaboration between physicians and NET experts
- Support patients and raise awareness